Approval · Notice of Compliance 4958 · 1995
CODEINE CONTIN: Notice of Compliance 4958
Issued June 2, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4958
- Date
- June 2, 1995
- Company
- Purdue Frederick
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Opioid analgesic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CODEINE CONTIN | 02163748 | Marketed |
| CODEINE CONTIN | 02163780 | Marketed |
| CODEINE CONTIN | 02163799 | Marketed |
Medicinal ingredients
- CODEINE SULFATE 100 MG per TAB
- CODEINE SULFATE 150 MG per TAB
- CODEINE SULFATE 200 MG per TAB